|
|
Effectiveness of Influenza Vaccine against Influenza A in Europe in Seasons of Different A(H1N1)Pdm09 and the Same A(H3N2) Vaccine Components (2016\textendash 17 and 2017\textendash 18)
Esther Kissling
,
Francisco Pozo
,
Silke Buda
,
Ana-Maria Vilcu
,
Caterina Rizzo
,
et al.
Journal articles
hal-03846533v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis
Maria van Kerkhove
,
Katelijn a H Vandemaele
,
Vivek Shinde
,
Giovanna Jaramillo-Gutierrez
,
Artemis Koukounari
,
et al.
Journal articles
pasteur-01665262v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
Gianfranco Spiteri
,
James Fielding
,
Michaela Diercke
,
Christine Campese
,
Vincent Enouf
,
et al.
Journal articles
pasteur-04098523v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Low 2018/19 Vaccine Effectiveness against Influenza A(H3N2) among 15\textendash 64-Year-Olds in Europe: Exploration by Birth Cohort
Esther Kissling
,
Francisco Pozo
,
Silke Buda
,
Ana-Maria Vilcu
,
Alin Gherasim
,
et al.
Journal articles
hal-03846534v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
Esther Kissling
,
Francisco Pozo
,
Iván Martínez-Baz
,
Silke Buda
,
Ana‐maria Vilcu
,
et al.
Journal articles
pasteur-04097905v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|